Human & Experimental Toxicology · 2019 · 14 citations · 23 references
MedicinePharmacologyToxicologyRenal PathologyRenal PathophysiologyRenal PharmacokineticsNephrotoxicity MechanismsRenal DiseaseRenal Function TestsRenal PharmacologyRenal ToxicityUrinary ExcretionBlood Urea Nitrogen To Creatinine RatioCreatinine-based BiomarkersRenal Biomarker DiscoveryRenal Biomarker MonitoringRenal Biomarkers Of ToxicityRenal Toxicity GradingSerum Creatinine AssessmentUrinary Urea Nitrogen
The aim of this study was to identify biomarkers of zoledronate-induced nephrotoxicity and to further characterize the mechanisms underlying this process by analyzing urinary metabolites. Twenty-four rats were randomly divided into four groups containing four (two control groups) or eight rats (two zoledronate groups) per group. The rats were injected intravenously with saline or zoledronate (3 mg/kg) singly (single, 3 weeks) or repeatedly eight times (3 weeks/time, 24 weeks). Serum blood urea nitrogen, serum creatinine, creatinine clearance, and kidney injury observed by hematoxylin and eosin and immunohistochemical staining were changed only in the repeated zoledronate group (3 mg/kg, 3 weeks/time, 24 weeks). Urinary levels of S-adenosylmethionine, S-adenosylhomocysteine, l-cystathionine, l-γ-glutamylcysteine, and glutathione related to glutathione metabolism and fumaric acid and succinic acid related to the tricarboxylic acid cycle in the zoledronate-treated group (3 mg/kg, 3 weeks/time, 24 weeks) were significantly lower than those in the control group, suggesting that zoledronate may cause cellular oxidative stress. Besides, urinary levels of uracil and uridine related to pyrimidine metabolism also decreased after zoledronate treatment (3 mg/kg, 3 weeks/time, 24 weeks), while the levels of hypoxanthine related to purine metabolism, histamine related to histamine metabolism, and several amino acids were significantly increased. Moreover, zoledronate-induced enhanced oxidative stress and histamine overproduction were confirmed by reactive oxygen species (ROS) and histamine measurement in a human proximal tubular cell line. Taken together, zoledronate-induced nephrotoxicity may be attributed to it inducing perturbations in glutathione biosynthesis and the tricarboxylic acid cycle, further causing ROS overproduction, oxidative stress, and cellular inflammation, thereby leading to nephrotoxicity.
23
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
Anne J. Ridley, Hugh F. Paterson, Caroline L. Johnston et al. · Cell · 1992 · 3.7K citations
Lee S. Rosen, David Gordon, Mary Kaminski et al. · PubMed · 2002 · 899 citations
Lee S. Rosen, David Gordon, Simon Tchekmedyian et al. · Journal of Clinical Oncology · 2003 · 727 citations
Medicine, Oncology, Pharmacotherapy +17
Cellular and molecular mechanisms of action of bisphosphonates
Michael J. Rogers, Sharon Gordon, Helena L. Benford et al. · Cancer · 2000 · 712 citations · Full text